Jeffrey K Tobias Insider Trading $JAZZ Jazz Pharmaceuticals plc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeffrey K Tobias.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey K Tobias. Jeffrey K Tobias is EVP, Research & Dev and CMO in Jazz Pharmaceuticals plc ($JAZZ).
Jeffrey K Tobias in Jazz Pharmaceuticals plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey K Tobias: EVP, Research & Dev and CMO
Holdings: 34,940 shares
Current Value: $4,369,247
Latest Transaction: Nov 25 2014
$JAZZ Market Capitalization: $7.62B
$JAZZ Previous Close: $125.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jeffrey K Tobias in Jazz Pharmaceuticals plc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 25 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 170.12 | 4,598 | 782,231 | 34,940 | 39.5 K to 34.9 K (-11.63 %) |
| Nov 18 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 173.32 | 1,000 | 173,320 | 39,538 | 40.5 K to 39.5 K (-2.47 %) |
| Oct 14 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 154.04 | 1,000 | 154,040 | 40,538 | 41.5 K to 40.5 K (-2.41 %) |
| Sep 15 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 171.22 | 1,000 | 171,220 | 41,538 | 42.5 K to 41.5 K (-2.35 %) |
| Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 59.13 | 2,372 | 140,256 | 17,187 | |
| Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 46.83 | 2,561 | 119,932 | 30,019 | |
| Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 135.42 | 4,933 | 668,027 | 42,538 | 47.5 K to 42.5 K (-10.39 %) |
| Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 59.13 | 2,372 | 140,256 | 47,471 | 45.1 K to 47.5 K (+5.26 %) |
| Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 46.83 | 2,561 | 119,932 | 45,099 | 42.5 K to 45.1 K (+6.02 %) |
| Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Payment of Exercise | F | 133.86 | 4,565 | 611,071 | 42,538 | 47.1 K to 42.5 K (-9.69 %) |
| Jun 11 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 59.13 | 439 | 25,958 | 19,559 | |
| Jun 11 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 46.83 | 2,561 | 119,932 | 32,580 | |
| Jun 11 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 146.24 | 3,000 | 438,720 | 47,103 | 50.1 K to 47.1 K (-5.99 %) |
| Jun 11 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 59.13 | 439 | 25,958 | 50,103 | 49.7 K to 50.1 K (+0.88 %) |
| Jun 11 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 46.83 | 2,561 | 119,932 | 49,664 | 47.1 K to 49.7 K (+5.44 %) |
| May 20 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 128.01 | 1,000 | 128,010 | 47,103 | 48.1 K to 47.1 K (-2.08 %) |
| Apr 16 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 59.13 | 1,720 | 101,704 | 19,998 | |
| Apr 16 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 46.83 | 1,280 | 59,942 | 35,141 | |
| Apr 16 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 128.54 | 3,000 | 385,620 | 48,103 | 51.1 K to 48.1 K (-5.87 %) |
| Apr 16 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 59.13 | 1,720 | 101,704 | 51,103 | 49.4 K to 51.1 K (+3.48 %) |
| Apr 16 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 46.83 | 1,280 | 59,942 | 49,383 | 48.1 K to 49.4 K (+2.66 %) |
| Mar 12 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 59.13 | 1,719 | 101,644 | 21,718 | |
| Mar 12 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 46.83 | 1,281 | 59,989 | 36,421 | |
| Mar 12 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 152.99 | 3,000 | 458,970 | 48,103 | 51.1 K to 48.1 K (-5.87 %) |
| Mar 12 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 59.13 | 1,719 | 101,644 | 51,103 | 49.4 K to 51.1 K (+3.48 %) |
| Mar 12 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 46.83 | 1,281 | 59,989 | 49,384 | 48.1 K to 49.4 K (+2.66 %) |
| Mar 06 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Payment of Exercise | F | 157.60 | 1,174 | 185,022 | 48,103 | 49.3 K to 48.1 K (-2.38 %) |
| Mar 03 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | A | 166.62 | 645 | 107,470 | 645 | |
| Mar 03 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | A | 166.62 | 14,355 | 2,391,830 | 14,355 | |
| Mar 03 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Grant | A | 0.00 | 7,500 | 0 | 49,277 | 41.8 K to 49.3 K (+17.95 %) |
| Mar 03 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 165.46 | 3,000 | 496,380 | 41,777 | 44.8 K to 41.8 K (-6.70 %) |
| Feb 12 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 46.83 | 2,560 | 119,885 | 37,702 | |
| Feb 12 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 152.83 | 2,560 | 391,245 | 44,777 | 47.3 K to 44.8 K (-5.41 %) |
| Feb 12 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 46.83 | 2,560 | 119,885 | 47,337 | 44.8 K to 47.3 K (+5.72 %) |
| Dec 11 2013 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 46.83 | 1,325 | 62,050 | 40,262 | |
| Dec 11 2013 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 117.80 | 1,325 | 156,085 | 44,777 | 46.1 K to 44.8 K (-2.87 %) |
| Dec 11 2013 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 46.83 | 1,325 | 62,050 | 46,102 | 44.8 K to 46.1 K (+2.96 %) |
| Nov 13 2013 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 46.83 | 2,373 | 111,128 | 41,587 | |
| Nov 13 2013 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 98.50 | 2,373 | 233,741 | 44,405 | 46.8 K to 44.4 K (-5.07 %) |
| Nov 13 2013 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 46.83 | 2,373 | 111,128 | 46,778 | 44.4 K to 46.8 K (+5.34 %) |
| Oct 16 2013 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 46.83 | 5,000 | 234,150 | 43,960 | |
| Oct 16 2013 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 83.31 | 600 | 49,986 | 44,405 | 45 K to 44.4 K (-1.33 %) |
| Oct 16 2013 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 82.53 | 4,400 | 363,132 | 45,005 | 49.4 K to 45 K (-8.91 %) |
| Oct 16 2013 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 46.83 | 5,000 | 234,150 | 49,405 | 44.4 K to 49.4 K (+11.26 %) |
| Sep 10 2013 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 46.83 | 5,000 | 234,150 | 48,960 | |
| Sep 10 2013 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 87.11 | 5,000 | 435,550 | 44,405 | 49.4 K to 44.4 K (-10.12 %) |
| Sep 10 2013 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 46.83 | 5,000 | 234,150 | 49,405 | 44.4 K to 49.4 K (+11.26 %) |
| Aug 13 2013 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 46.83 | 7,500 | 351,225 | 54,140 | |
| Aug 13 2013 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 80.77 | 7,500 | 605,775 | 44,405 | 51.9 K to 44.4 K (-14.45 %) |
| Aug 13 2013 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 46.83 | 7,500 | 351,225 | 51,905 | 44.4 K to 51.9 K (+16.89 %) |
| Aug 13 2013 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Payment of Exercise | F | 80.88 | 3,288 | 265,933 | 44,405 | 47.7 K to 44.4 K (-6.89 %) |
| Mar 06 2013 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | A | 59.13 | 1,563 | 92,420 | 1,563 | |
| Mar 06 2013 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | A | 59.13 | 23,437 | 1,385,830 | 23,437 | |
| Mar 06 2013 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Grant | A | 0.00 | 12,500 | 0 | 47,500 | 35 K to 47.5 K (+35.71 %) |
| Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | A | 46.83 | 70,000 | 3,278,100 | 70,000 | |
| Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Grant | A | 0.00 | 35,000 | 0 | 35,000 | 0 to 35 K |
Page: 1